# Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy

> **NCT02302547** · PHASE3 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 224 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** triple therapy
- **DRUG:** dual therapy

## Key facts

- **NCT ID:** NCT02302547
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-08-23
- **Final completion:** 2018-09-21
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302547, "Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02302547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*